CompareMarketResearchRequest a sample
Home / Healthcare / Gene Synthesis

Healthcare · Market report

Gene Synthesis Market Size, Share and Forecast 2026-2036

The global gene synthesis market is worth USD 2.8 bn in 2026 and is forecast to reach USD 11.2 bn by 2036, growing at a 15.0% CAGR. United States is the largest country market and Gene fragments and clonal genes is the largest by product segment.

USD 2.8 bnMarket size 2026
USD 11.2 bnForecast 2036
15.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global gene synthesis market is worth USD 2.8 bn in 2026 and is forecast to reach USD 11.2 bn by 2036, growing at a 15.0% CAGR. United States is the largest country market and Gene fragments and clonal genes is the largest by product segment.

ScopeCustom synthesis of DNA fragments, genes, gene libraries and oligonucleotide pools sold as services and benchtop synthesizers to research, biopharma and synthetic biology customers.
IndustryHealthcare
Value 2025USD 2.4 bn
Value 2026USD 2.8 bn
Value 2036USD 11.2 bn
CAGR 2026-203615.0%
Volume 20266,229 million base pairs
Volume 203637,905 million base pairs
Average price 2026USD 0.44 per base pair
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Gene Synthesis market size and forecast, 2026-2036

Exhibit 1The global gene synthesis market is forecast to grow from USD 2.8 bn in 2026 to USD 11.2 bn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 15.0%
Gene Synthesis market value, 2025 to 2036Market value by year. 2025: USD 2.4 bn; 2026: USD 2.8 bn; 2027: USD 3.2 bn; 2028: USD 3.7 bn; 2029: USD 4.2 bn; 2030: USD 4.8 bn; 2031: USD 5.6 bn; 2032: USD 6.4 bn; 2033: USD 7.3 bn; 2034: USD 8.4 bn; 2035: USD 9.7 bn; 2036: USD 11.2 bn. Compound annual growth rate 2026 to 2036: 15.0%.20252.8 bn20265.6 bn203111.2 bn203615.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 2.8 bn
2027USD 3.2 bn
2028USD 3.7 bn
2029USD 4.2 bn
2030USD 4.8 bn
2031USD 5.6 bn
2032USD 6.4 bn
2033USD 7.3 bn
2034USD 8.4 bn
2035USD 9.7 bn
2036USD 11.2 bn

Gene Synthesis market segmentation

By product

Exhibit 2Gene fragments and clonal genes is the largest segment by product, with 52.0% of 2026 revenueEstimated share of 2026 global revenue, by product
Gene Synthesis market share by product, 2026Share of 2026 revenue by product. Gene fragments and clonal genes: 52.0%; Oligonucleotide pools and libraries: 23.0%; Long and complex constructs: 15.0%; Synthesizers and enzymatic kits: 10.0%.Gene fragments and clonal genes52.0%Oligonucleotide pools and libraries23.0%Long and complex constructs15.0%Synthesizers and enzymatic kits10.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Gene fragments and clonal genes52.0%45.7%USD 1.4 bn13.5%
Oligonucleotide pools and libraries23.0%26.2%USD 635 mn16.5%
Long and complex constructs15.0%15.7%USD 414 mn15.5%
Synthesizers and enzymatic kits10.0%12.4%USD 276 mn17.5%

By end user

Exhibit 3Biopharma and biotech adds the most revenue by end user, growing from USD 1.2 bn in 2026 to USD 5.4 bn by 2036Estimated revenue in USD by end user, 2026 and 2036 forecast
Gene Synthesis market by end user, 2026 and 2036Revenue by end user in 2026 and 2036. Biopharma and biotech: USD 1.2 bn in 2026, USD 5.4 bn in 2036, change +341%; Academic and research institutes: USD 773 mn in 2026, USD 2.4 bn in 2036, change +210%; Industrial and agricultural biotech: USD 386 mn in 2026, USD 1.9 bn in 2036, change +380%; Diagnostics and CROs: USD 386 mn in 2026, USD 1.6 bn in 2036, change +304%.20262036 forecastChangeBiopharma and biotech+341%1.2 bn5.4 bnAcademic and research institutes+210%773 mn2.4 bnIndustrial and agricultural biotech+380%386 mn1.9 bnDiagnostics and CROs+304%386 mn1.6 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Biopharma and biotech44.0%47.9%USD 1.2 bn16.0%
Academic and research institutes28.0%21.5%USD 773 mn12.0%
Diagnostics and CROs14.0%14.0%USD 386 mn15.0%
Industrial and agricultural biotech14.0%16.6%USD 386 mn17.0%

By technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Phosphoramidite chemical synthesis64.0%50.0%USD 1.8 bn12.2%
Enzymatic synthesis14.0%30.0%USD 386 mn24.1%
Microarray-based synthesis22.0%20.0%USD 607 mn13.9%

By gene length

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Up to 500 base pairs36.0%32.0%USD 994 mn13.7%
Mid length40.0%40.0%USD 1.1 bn15.0%
Long constructs24.0%28.0%USD 662 mn16.8%

By application

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Therapeutic and vaccine development32.0%33.0%USD 883 mn15.3%
Synthetic biology and protein engineering28.0%30.0%USD 773 mn15.8%
Diagnostics14.0%14.0%USD 386 mn15.0%
Basic research26.0%23.0%USD 718 mn13.6%

Top 25 countries for gene synthesis by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 89.5% of 2026 revenue and the 25 countries below together hold 97.3%.

Exhibit 4United States is the largest country market at USD 1.2 bn in 2026, and the three largest countries hold 63.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Gene Synthesis market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 1.2 bn, 42.0%; China: USD 386 mn, 14.0%; Germany: USD 193 mn, 7.0%; United Kingdom: USD 166 mn, 6.0%; Japan: USD 138 mn, 5.0%; France: USD 110 mn, 4.0%; Switzerland: USD 83 mn, 3.0%; Canada: USD 83 mn, 3.0%; South Korea: USD 83 mn, 3.0%; India: USD 69 mn, 2.5%.United States1.2 bn 42.0%China386 mn 14.0%Germany193 mn 7.0%United Kingdom166 mn 6.0%Japan138 mn 5.0%France110 mn 4.0%Switzerland83 mn 3.0%Canada83 mn 3.0%South Korea83 mn 3.0%India69 mn 2.5%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 1.2 bn42.0%USD 4.4 bn14.2%
2ChinaUSD 386 mn14.0%USD 2.2 bn19.2%
3GermanyUSD 193 mn7.0%USD 670 mn13.2%
4United KingdomUSD 166 mn6.0%USD 569 mn13.2%
5JapanUSD 138 mn5.0%USD 435 mn12.2%
6FranceUSD 110 mn4.0%USD 380 mn13.2%
7SwitzerlandUSD 83 mn3.0%USD 290 mn13.4%
8CanadaUSD 83 mn3.0%USD 313 mn14.2%
9South KoreaUSD 83 mn3.0%USD 368 mn16.1%
10IndiaUSD 69 mn2.5%USD 368 mn18.2%
11NetherlandsUSD 21 mn0.8%USD 84 mn14.8%
12AustraliaUSD 21 mn0.8%USD 84 mn14.8%
13SingaporeUSD 18 mn0.7%USD 90 mn17.6%
14DenmarkUSD 18 mn0.7%USD 73 mn15.0%
15SpainUSD 15 mn0.5%USD 60 mn15.0%
16ItalyUSD 15 mn0.5%USD 60 mn15.0%
17SwedenUSD 15 mn0.5%USD 60 mn15.0%
18BelgiumUSD 15 mn0.5%USD 60 mn15.0%
19IsraelUSD 15 mn0.5%USD 60 mn15.0%
20BrazilUSD 12 mn0.4%USD 60 mn17.6%
21TaiwanUSD 12 mn0.4%USD 48 mn15.0%
22IrelandUSD 12 mn0.4%USD 48 mn15.0%
23AustriaUSD 8.8 mn0.3%USD 36 mn15.0%
24FinlandUSD 8.8 mn0.3%USD 36 mn15.0%
25NorwayUSD 8.8 mn0.3%USD 36 mn15.0%
Rest of worldUSD 75 mn2.7%USD 288 mn14.3%
Exhibit 5United States and China account for 60% of the USD 8.4 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Gene Synthesis market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 2.8 bn. United States: +USD 3.2 bn; China: +USD 1.8 bn; Germany: +USD 477 mn; United Kingdom: +USD 404 mn; India: +USD 299 mn; 20 other countries: +USD 2.0 bn; Rest of world: +USD 213 mn. Market value 2036: USD 11.2 bn.Market value 20262.8 bnUnited States+3.2 bnChina+1.8 bnGermany+477 mnUnited Kingdom+404 mnIndia+299 mn20 other countries+2.0 bnRest of world+213 mnMarket value 203611.2 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Twist Bioscience
  • GenScript
  • Integrated DNA Technologies
  • Thermo Fisher Scientific
  • Eurofins Genomics
  • Azenta Life Sciences
  • Sangon Biotech
  • Merck KGaA

Group 2: Regional and specialist players

  • Telesis Bio
  • Ansa Biotechnologies
  • Ribbon Biolabs
  • Tsingke Biotechnology
  • ATUM
  • Synbio Technologies
  • OriGene Technologies
  • Bio Basic
  • Biomatik
  • Eton Bioscience

Group 3: Emerging and niche players

  • Elegen
  • DNA Script
  • Evonetix
  • Moligo Technologies
  • Camena Bioscience
  • Molecular Assemblies

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the gene synthesis market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 15.0% is calculated from the resulting values.

The market is divided by product, by end user, by technology, by gene length, by application. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the gene synthesis market?

The global gene synthesis market is estimated at USD 2.4 bn in 2025 and USD 2.8 bn in 2026.

How fast will the gene synthesis market grow?

It is forecast to reach USD 11.2 bn by 2036, a compound annual growth rate of 15.0% from 2026, an increase of USD 8.4 bn.

Which country is the largest market for gene synthesis?

United States is the largest market by revenue at USD 1.2 bn in 2026, 42.0% of the global total. The three largest countries together hold 63.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 19.2% a year from 2026 to 2036.

Which gene synthesis segment is largest?

In the by product split, Gene fragments and clonal genes is the largest segment with 52.0% of 2026 revenue.

Who are the leading gene synthesis companies?

Global leaders include Twist Bioscience, GenScript, Integrated DNA Technologies, Thermo Fisher Scientific.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Frozen Clinical Meal Gene Therapy →

All Healthcare markets →

Request a sample